Thölking Gerold, Gerth Hans Ulrich, Schuette-Nuetgen Katharina, Reuter Stefan
Gerold Thölking, Hans Ulrich Gerth, Katharina Schuette-Nuetgen, Stefan Reuter, Division of General Internal Medicine, Nephrology and Rheumatology, Department of Medicine D, University Hospital of Münster, 48149 Münster, Germany.
World J Transplant. 2017 Feb 24;7(1):26-33. doi: 10.5500/wjt.v7.i1.26.
The calcineurin inhibitor (CNI) tacrolimus (TAC) is an integral part of the immunosuppressive regimen after solid organ transplantation. Although TAC is very effective in prevention of acute rejection episodes, its highly variable pharmacokinetic and narrow therapeutic window require frequent monitoring of drug levels and dose adjustments. TAC can cause CNI nephrotoxicity even at low blood trough levels (4-6 ng/mL). Thus, other factors besides the TAC trough level might contribute to CNI-related kidney injury. Unfortunately, TAC pharmacokinetic is determined by a whole bunch of parameters. However, for daily clinical routine a simple application strategy is needed. To address this problem, we and others have evaluated a simple calculation method in which the TAC blood trough concentration (C) is divided by the daily dose (D). Fast TAC metabolism (C/D ratio < 1.05) was identified as a potential risk factor for an inferior kidney function after transplantation. In this regard, we recently showed a strong association between fast TAC metabolism and CNI nephrotoxicity as well as BKV infection. Therefore, the TAC C/D ratio may assist transplant clinicians in a simple way to individualize the immunosuppressive regimen.
钙调神经磷酸酶抑制剂(CNI)他克莫司(TAC)是实体器官移植后免疫抑制方案的重要组成部分。尽管TAC在预防急性排斥反应方面非常有效,但其药代动力学高度可变且治疗窗狭窄,需要频繁监测药物水平并调整剂量。即使在低血药谷浓度(4 - 6 ng/mL)时,TAC也可能导致CNI肾毒性。因此,除了TAC血药谷浓度外,其他因素可能也与CNI相关的肾损伤有关。不幸的是,TAC的药代动力学由一大堆参数决定。然而,对于日常临床常规操作,需要一种简单的应用策略。为了解决这个问题,我们和其他人评估了一种简单的计算方法,即将TAC血药谷浓度(C)除以每日剂量(D)。快速的TAC代谢(C/D比值 < 1.05)被确定为移植后肾功能较差的一个潜在危险因素。在这方面,我们最近表明快速的TAC代谢与CNI肾毒性以及BK病毒感染之间存在密切关联。因此,TAC的C/D比值可能以一种简单的方式帮助移植临床医生个体化免疫抑制方案。